Recombinant FVIII (Kogenate) treatment of previously untreated patients (PUPs) with hemophilia A: update of safety, efficacy and inhibitor development after seven study years. The Kogenate PUP Study Group (Abst PD-664) - Lusher,J.M.; Arkin,S.; Abildgaard,C.F.; Hurst,D. (Thromb Haemost, 1997)